Emergency Contraception in Belgium

August 2013 | 30 pages | ID: EA373A2335EEN
Euromonitor International Ltd

Abstracts

At the end of 2012, local press announced there were 19,578 abortions in 2011 in Belgium; an increase of 500 compared with 2010. This most affects women aged 20-35 – and not teenagers – converse to what some sources believed. Seven out of 10 are not married, and 40% consider they are two young, are still studying or do not want children.

Euromonitor International's Emergency Contraception in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Emergency Contraception: Value 2007-2012
  Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
  Table 3 Emergency Contraception Company Shares by Value 2008-2012
  Table 4 Emergency Contraception Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
  Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Executive Summary
2012 Is Not A Good Year for Consumer Health
More Repressive Juridical Context Than Deregulation
Multinationals Are the Most Affected
Distribution Remains Under the Control of Chemists/pharmacies, Despite Some Changes
Bleak Prospects Overall
Key Trends and Developments
the Outlook Is Clouding Over for Consumer Health
Health and Wellness Called To Order
Local Authorities and Experts Do Not Help Matters
Urgent Need for Calm
Local Environment Leaves More Limited Room for Manoeuvre for Multinationals
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Penetration of Private Label by Category 2007-2012
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Generics
Switches
Summary 1 OTC: Switches 2010-2012
Sources
Summary 2 Research Sources